within Pharmacolibrary.Drugs.ATC.A;

model A06AC08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 1250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A06AC08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Polycarbophil calcium is a synthetic, high molecular weight, insoluble polymer used primarily as a bulk-forming laxative to treat occasional constipation and to help maintain regular bowel movements. It swells in the intestine by absorbing water, thereby facilitating softer and bulkier stools. Polycarbophil calcium is approved and in use today for the management of constipation and sometimes for irritable bowel syndrome.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adults, general population. No direct systemic absorption, acts locally in the gastrointestinal tract.</p><h4>References</h4><ol><li><p>Kato, R, et al., &amp; Ueno, K (2002). Impairment of mycophenolate mofetil absorption by calcium polycarbophil. <i>Journal of clinical pharmacology</i> 42(11) 1275–1280. DOI:<a href=\"https://doi.org/10.1177/009127002762491389\">10.1177/009127002762491389</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12412828/\">https://pubmed.ncbi.nlm.nih.gov/12412828</a></p></li><li><p>Perera, G, et al., &amp; Bernkop-Schnürch, A (2011). Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate. <i>Drug delivery</i> 18(6) 415–423. DOI:<a href=\"https://doi.org/10.3109/10717544.2011.570807\">10.3109/10717544.2011.570807</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21554106/\">https://pubmed.ncbi.nlm.nih.gov/21554106</a></p></li><li><p>Wasnik, MN, et al., &amp; Nair, HA (2014). Development and evaluation of buccoadhesive tablet for selegiline hydrochloride based on thiolated polycarbophil. <i>Drug development and industrial pharmacy</i> 40(5) 632–638. DOI:<a href=\"https://doi.org/10.3109/03639045.2014.884124\">10.3109/03639045.2014.884124</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24517570/\">https://pubmed.ncbi.nlm.nih.gov/24517570</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A06AC08;
